Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Placebo Control Design”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00319137
What this trial is testing

An Adaptive Design Trial Of GW274150 In The Treatment Of Acute Migraine

Who this might be right for
Migraine DisordersMigraine
GlaxoSmithKline 126
Testing effectiveness (Phase 2)Study completedNCT00191724
What this trial is testing

Adjuvant Treatment of Pulmonary Embolism With Drotrecogin Alfa (Activated): Phase II Exploratory Study

Who this might be right for
Submassive Pulmonary Embolism
Eli Lilly and Company 47
Large-scale testing (Phase 3)Study completedNCT01722331
What this trial is testing

Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)

Who this might be right for
Plaque Psoriasis
Sun Pharmaceutical Industries Limited 772
Early research (Phase 1)Study completedNCT03794323
What this trial is testing

A Study in Healthy Men to Find Out How Well Different Doses of BI 764122 Are Tolerated and Whether Food Affects the Amount of BI 764122 in the Blood

Who this might be right for
Healthy
Boehringer Ingelheim 76
Early research (Phase 1)Study completedNCT03754959
What this trial is testing

This Study in Healthy Men Tests How Different Doses of BI 1358894 Are Taken up in the Body and How Well They Are Tolerated. The Study Also Tests How BI 1358894 Affects the Way the Body Breaks Down Midazolam

Who this might be right for
Healthy
Boehringer Ingelheim 50
Early research (Phase 1)Study completedNCT02748694
What this trial is testing

Phase 1 TAK-041 First-in-Human Safety, Tolerability, and Pharmacokinetics Study

Who this might be right for
Healthy VolunteersSchizophrenia
Neurocrine Biosciences 114
Testing effectiveness (Phase 2)Study completedNCT00412646
What this trial is testing

TMC125-C203: Phase II Randomized (Patients Are Assigned Different Treatments Based on Chance), Placebo Controlled Dose Escalating Trial of TMC125 in HIV-1 Infected Patients

Who this might be right for
Anti-Retroviral AgentsHIV-1
Tibotec Pharmaceuticals, Ireland 260
Large-scale testing (Phase 3)Study completedNCT00274573
What this trial is testing

Effects of Once Daily Tiotropium in Patients With Chronic Obstructive Pulmonary Disease (COPD) of Different Severity

Who this might be right for
Pulmonary Disease, Chronic Obstructive
Boehringer Ingelheim 1,639
Large-scale testing (Phase 3)UnknownNCT05054842
What this trial is testing

Clinical Study of Retagliptin Phosphate Combined With Metformin in the Treatment of Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Jiangsu HengRui Medicine Co., Ltd. 174
Testing effectiveness (Phase 2)Study completedNCT02888080
What this trial is testing

Study of Efficacy, Safety and Tolerability of ACZ885 (Canakinumab) in Patients With Pulmonary Sarcoidosis

Who this might be right for
Pulmonary Sarcoidosis
Novartis Pharmaceuticals 40
Large-scale testing (Phase 3)Study completedNCT00563368
What this trial is testing

A Study Comparing Multiple Doses of VI-0521 With Placebo and Their Single-agent Constituents for Treatment of Obesity in Adults

Who this might be right for
Obesity
VIVUS LLC 756
Early research (Phase 1)Ended earlyNCT05183360
What this trial is testing

A Study in Healthy Japanese and Chinese Men to Test How Well Different Doses of BI 706321 Are Tolerated

Who this might be right for
Healthy
Boehringer Ingelheim 48
Early research (Phase 1)Ended earlyNCT04445090
What this trial is testing

A Study in Healthy Men to Test How Well Different Doses of BI 1569912 Are Tolerated and How Food Influences the Amount of BI 1569912 in the Blood

Who this might be right for
Healthy
Boehringer Ingelheim 68
Large-scale testing (Phase 3)WithdrawnNCT05550350
What this trial is testing

Evaluate the Efficacy and Safety of DEXYCU® for the Treatment of Ocular Pain Associated With Cataract Surgery

Who this might be right for
Cataract
EyePoint Pharmaceuticals, Inc.
Large-scale testing (Phase 3)Study completedNCT00126061
What this trial is testing

Intravenous Tedisamil in the Rapid Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm in Male Subjects

Who this might be right for
Atrial FibrillationAtrial Flutter
Solvay Pharmaceuticals
Early research (Phase 1)Study completedNCT01929161
What this trial is testing

Study of Wellness Behaviors as a Function of Oxytocin vs Placebo

Who this might be right for
Sustained Positive EmotionsSustained Positive Behavior Change
University of North Carolina, Chapel Hill 239
Not applicableEnded earlyNCT00978341
What this trial is testing

Study to Determine if a Reduction in Pain Can be Measured in Spinal Cord Injured Patients Using a New Study Design

Who this might be right for
Spinal Cord Injuries
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 15
Large-scale testing (Phase 3)UnknownNCT04179604
What this trial is testing

Spanish Randomized Clinical Trial to Compare Levosimendan Versus Placebo in Postoperative Cardiac Surgery (SPARTANS)

Who this might be right for
Cardiac Output, Low
María de los Ángeles Tena Pajuelo 300
Testing effectiveness (Phase 2)Study completedNCT03370887
What this trial is testing

AZD8601 Study in CABG Patients

Who this might be right for
Heart Failure
AstraZeneca 11
Testing effectiveness (Phase 2)Study completedNCT04824391
What this trial is testing

Efficacy, Immunogenicity and Safety of Inactivated ERUCOV-VAC Compared With Placebo in COVID-19

Who this might be right for
COVID-19
Health Institutes of Turkey 250
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation